Global Oxcarbazepine Market Insights, Forecast to 2028

Global Oxcarbazepine Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Oxcarbazepine Product Introduction
1.2 Market by Type
1.2.1 Global Oxcarbazepine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets (150mg, 300mg, 600mg)
1.2.3 Oral Suspension
1.3 Market by Application
1.3.1 Global Oxcarbazepine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pediatric Use (Aged 2-4 years, 4-16 years)
1.3.3 Adult Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oxcarbazepine Sales Estimates and Forecasts 2017-2028
2.2 Global Oxcarbazepine Revenue Estimates and Forecasts 2017-2028
2.3 Global Oxcarbazepine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oxcarbazepine Sales by Region
2.4.1 Global Oxcarbazepine Sales by Region (2017-2022)
2.4.2 Global Sales Oxcarbazepine by Region (2023-2028)
2.5 Global Oxcarbazepine Revenue by Region
2.5.1 Global Oxcarbazepine Revenue by Region (2017-2022)
2.5.2 Global Oxcarbazepine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oxcarbazepine Sales by Manufacturers
3.1.1 Global Top Oxcarbazepine Manufacturers by Sales (2017-2022)
3.1.2 Global Oxcarbazepine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oxcarbazepine in 2021
3.2 Global Oxcarbazepine Revenue by Manufacturers
3.2.1 Global Oxcarbazepine Revenue by Manufacturers (2017-2022)
3.2.2 Global Oxcarbazepine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oxcarbazepine Revenue in 2021
3.3 Global Oxcarbazepine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oxcarbazepine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oxcarbazepine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oxcarbazepine Sales by Type
4.1.1 Global Oxcarbazepine Historical Sales by Type (2017-2022)
4.1.2 Global Oxcarbazepine Forecasted Sales by Type (2023-2028)
4.1.3 Global Oxcarbazepine Sales Market Share by Type (2017-2028)
4.2 Global Oxcarbazepine Revenue by Type
4.2.1 Global Oxcarbazepine Historical Revenue by Type (2017-2022)
4.2.2 Global Oxcarbazepine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oxcarbazepine Revenue Market Share by Type (2017-2028)
4.3 Global Oxcarbazepine Price by Type
4.3.1 Global Oxcarbazepine Price by Type (2017-2022)
4.3.2 Global Oxcarbazepine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oxcarbazepine Sales by Application
5.1.1 Global Oxcarbazepine Historical Sales by Application (2017-2022)
5.1.2 Global Oxcarbazepine Forecasted Sales by Application (2023-2028)
5.1.3 Global Oxcarbazepine Sales Market Share by Application (2017-2028)
5.2 Global Oxcarbazepine Revenue by Application
5.2.1 Global Oxcarbazepine Historical Revenue by Application (2017-2022)
5.2.2 Global Oxcarbazepine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oxcarbazepine Revenue Market Share by Application (2017-2028)
5.3 Global Oxcarbazepine Price by Application
5.3.1 Global Oxcarbazepine Price by Application (2017-2022)
5.3.2 Global Oxcarbazepine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oxcarbazepine Market Size by Type
6.1.1 North America Oxcarbazepine Sales by Type (2017-2028)
6.1.2 North America Oxcarbazepine Revenue by Type (2017-2028)
6.2 North America Oxcarbazepine Market Size by Application
6.2.1 North America Oxcarbazepine Sales by Application (2017-2028)
6.2.2 North America Oxcarbazepine Revenue by Application (2017-2028)
6.3 North America Oxcarbazepine Market Size by Country
6.3.1 North America Oxcarbazepine Sales by Country (2017-2028)
6.3.2 North America Oxcarbazepine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oxcarbazepine Market Size by Type
7.1.1 Europe Oxcarbazepine Sales by Type (2017-2028)
7.1.2 Europe Oxcarbazepine Revenue by Type (2017-2028)
7.2 Europe Oxcarbazepine Market Size by Application
7.2.1 Europe Oxcarbazepine Sales by Application (2017-2028)
7.2.2 Europe Oxcarbazepine Revenue by Application (2017-2028)
7.3 Europe Oxcarbazepine Market Size by Country
7.3.1 Europe Oxcarbazepine Sales by Country (2017-2028)
7.3.2 Europe Oxcarbazepine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oxcarbazepine Market Size by Type
8.1.1 Asia Pacific Oxcarbazepine Sales by Type (2017-2028)
8.1.2 Asia Pacific Oxcarbazepine Revenue by Type (2017-2028)
8.2 Asia Pacific Oxcarbazepine Market Size by Application
8.2.1 Asia Pacific Oxcarbazepine Sales by Application (2017-2028)
8.2.2 Asia Pacific Oxcarbazepine Revenue by Application (2017-2028)
8.3 Asia Pacific Oxcarbazepine Market Size by Region
8.3.1 Asia Pacific Oxcarbazepine Sales by Region (2017-2028)
8.3.2 Asia Pacific Oxcarbazepine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oxcarbazepine Market Size by Type
9.1.1 Latin America Oxcarbazepine Sales by Type (2017-2028)
9.1.2 Latin America Oxcarbazepine Revenue by Type (2017-2028)
9.2 Latin America Oxcarbazepine Market Size by Application
9.2.1 Latin America Oxcarbazepine Sales by Application (2017-2028)
9.2.2 Latin America Oxcarbazepine Revenue by Application (2017-2028)
9.3 Latin America Oxcarbazepine Market Size by Country
9.3.1 Latin America Oxcarbazepine Sales by Country (2017-2028)
9.3.2 Latin America Oxcarbazepine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oxcarbazepine Market Size by Type
10.1.1 Middle East and Africa Oxcarbazepine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oxcarbazepine Revenue by Type (2017-2028)
10.2 Middle East and Africa Oxcarbazepine Market Size by Application
10.2.1 Middle East and Africa Oxcarbazepine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oxcarbazepine Revenue by Application (2017-2028)
10.3 Middle East and Africa Oxcarbazepine Market Size by Country
10.3.1 Middle East and Africa Oxcarbazepine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oxcarbazepine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis (Trileptal)
11.1.1 Novartis (Trileptal) Corporation Information
11.1.2 Novartis (Trileptal) Overview
11.1.3 Novartis (Trileptal) Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis (Trileptal) Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis (Trileptal) Recent Developments
11.2 Supernus Pharmaceuticals (Oxtellar XR)
11.2.1 Supernus Pharmaceuticals (Oxtellar XR) Corporation Information
11.2.2 Supernus Pharmaceuticals (Oxtellar XR) Overview
11.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Developments
11.3 Sun Pharm
11.3.1 Sun Pharm Corporation Information
11.3.2 Sun Pharm Overview
11.3.3 Sun Pharm Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sun Pharm Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharm Recent Developments
11.4 Ranbaxy Pharmaceuticals
11.4.1 Ranbaxy Pharmaceuticals Corporation Information
11.4.2 Ranbaxy Pharmaceuticals Overview
11.4.3 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ranbaxy Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ranbaxy Pharmaceuticals Recent Developments
11.5 Jubilant Generics
11.5.1 Jubilant Generics Corporation Information
11.5.2 Jubilant Generics Overview
11.5.3 Jubilant Generics Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Jubilant Generics Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Jubilant Generics Recent Developments
11.6 Taro Pharmaceuticals
11.6.1 Taro Pharmaceuticals Corporation Information
11.6.2 Taro Pharmaceuticals Overview
11.6.3 Taro Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Taro Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Taro Pharmaceuticals Recent Developments
11.7 Mylan
11.7.1 Mylan Corporation Information
11.7.2 Mylan Overview
11.7.3 Mylan Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mylan Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mylan Recent Developments
11.8 Stada Group
11.8.1 Stada Group Corporation Information
11.8.2 Stada Group Overview
11.8.3 Stada Group Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Stada Group Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Stada Group Recent Developments
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Corporation Information
11.9.2 Glenmark Pharmaceuticals Overview
11.9.3 Glenmark Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Glenmark Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Glenmark Pharmaceuticals Recent Developments
11.10 ANI Pharmaceuticals
11.10.1 ANI Pharmaceuticals Corporation Information
11.10.2 ANI Pharmaceuticals Overview
11.10.3 ANI Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 ANI Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 ANI Pharmaceuticals Recent Developments
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Corporation Information
11.11.2 Teva Pharmaceutical Overview
11.11.3 Teva Pharmaceutical Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Teva Pharmaceutical Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Pharmaceutical Recent Developments
11.12 Roxane Laboratories
11.12.1 Roxane Laboratories Corporation Information
11.12.2 Roxane Laboratories Overview
11.12.3 Roxane Laboratories Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Roxane Laboratories Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Roxane Laboratories Recent Developments
11.13 Nobelpharma
11.13.1 Nobelpharma Corporation Information
11.13.2 Nobelpharma Overview
11.13.3 Nobelpharma Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Nobelpharma Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Nobelpharma Recent Developments
11.14 Apotex
11.14.1 Apotex Corporation Information
11.14.2 Apotex Overview
11.14.3 Apotex Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Apotex Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Apotex Recent Developments
11.15 Nexgen pharma
11.15.1 Nexgen pharma Corporation Information
11.15.2 Nexgen pharma Overview
11.15.3 Nexgen pharma Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Nexgen pharma Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Nexgen pharma Recent Developments
11.16 Amneal Pharmaceuticals
11.16.1 Amneal Pharmaceuticals Corporation Information
11.16.2 Amneal Pharmaceuticals Overview
11.16.3 Amneal Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Amneal Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Amneal Pharmaceuticals Recent Developments
11.17 Hikma Pharmaceuticals
11.17.1 Hikma Pharmaceuticals Corporation Information
11.17.2 Hikma Pharmaceuticals Overview
11.17.3 Hikma Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Hikma Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Hikma Pharmaceuticals Recent Developments
11.18 Jamp Pharma
11.18.1 Jamp Pharma Corporation Information
11.18.2 Jamp Pharma Overview
11.18.3 Jamp Pharma Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Jamp Pharma Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Jamp Pharma Recent Developments
11.19 Neuraxpharm
11.19.1 Neuraxpharm Corporation Information
11.19.2 Neuraxpharm Overview
11.19.3 Neuraxpharm Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Neuraxpharm Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Neuraxpharm Recent Developments
11.20 Orion Corporation
11.20.1 Orion Corporation Corporation Information
11.20.2 Orion Corporation Overview
11.20.3 Orion Corporation Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Orion Corporation Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Orion Corporation Recent Developments
11.21 Sihuan Pharm
11.21.1 Sihuan Pharm Corporation Information
11.21.2 Sihuan Pharm Overview
11.21.3 Sihuan Pharm Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Sihuan Pharm Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Sihuan Pharm Recent Developments
11.22 Humanwell Healthcare
11.22.1 Humanwell Healthcare Corporation Information
11.22.2 Humanwell Healthcare Overview
11.22.3 Humanwell Healthcare Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Humanwell Healthcare Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Humanwell Healthcare Recent Developments
11.23 Huikang Pharmaceutical
11.23.1 Huikang Pharmaceutical Corporation Information
11.23.2 Huikang Pharmaceutical Overview
11.23.3 Huikang Pharmaceutical Oxcarbazepine Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Huikang Pharmaceutical Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Huikang Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oxcarbazepine Industry Chain Analysis
12.2 Oxcarbazepine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oxcarbazepine Production Mode & Process
12.4 Oxcarbazepine Sales and Marketing
12.4.1 Oxcarbazepine Sales Channels
12.4.2 Oxcarbazepine Distributors
12.5 Oxcarbazepine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oxcarbazepine Industry Trends
13.2 Oxcarbazepine Market Drivers
13.3 Oxcarbazepine Market Challenges
13.4 Oxcarbazepine Market Restraints
14 Key Findings in The Global Oxcarbazepine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oxcarbazepine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablets (150mg, 300mg, 600mg)
Table 3. Major Manufacturers of Oral Suspension
Table 4. Global Oxcarbazepine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Oxcarbazepine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Oxcarbazepine Sales by Region (2017-2022) & (M Unit)
Table 7. Global Oxcarbazepine Sales Market Share by Region (2017-2022)
Table 8. Global Oxcarbazepine Sales by Region (2023-2028) & (M Unit)
Table 9. Global Oxcarbazepine Sales Market Share by Region (2023-2028)
Table 10. Global Oxcarbazepine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Oxcarbazepine Revenue Market Share by Region (2017-2022)
Table 12. Global Oxcarbazepine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Oxcarbazepine Revenue Market Share by Region (2023-2028)
Table 14. Global Oxcarbazepine Sales by Manufacturers (2017-2022) & (M Unit)
Table 15. Global Oxcarbazepine Sales Share by Manufacturers (2017-2022)
Table 16. Global Oxcarbazepine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Oxcarbazepine Revenue Share by Manufacturers (2017-2022)
Table 18. Oxcarbazepine Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Oxcarbazepine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Oxcarbazepine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxcarbazepine as of 2021)
Table 21. Oxcarbazepine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Oxcarbazepine Product Offered
Table 23. Date of Manufacturers Enter into Oxcarbazepine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 26. Global Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 27. Global Oxcarbazepine Sales Share by Type (2017-2022)
Table 28. Global Oxcarbazepine Sales Share by Type (2023-2028)
Table 29. Global Oxcarbazepine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Oxcarbazepine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Oxcarbazepine Revenue Share by Type (2017-2022)
Table 32. Global Oxcarbazepine Revenue Share by Type (2023-2028)
Table 33. Oxcarbazepine Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Oxcarbazepine Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 36. Global Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 37. Global Oxcarbazepine Sales Share by Application (2017-2022)
Table 38. Global Oxcarbazepine Sales Share by Application (2023-2028)
Table 39. Global Oxcarbazepine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Oxcarbazepine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Oxcarbazepine Revenue Share by Application (2017-2022)
Table 42. Global Oxcarbazepine Revenue Share by Application (2023-2028)
Table 43. Oxcarbazepine Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Oxcarbazepine Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 46. North America Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 47. North America Oxcarbazepine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Oxcarbazepine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 50. North America Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 51. North America Oxcarbazepine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Oxcarbazepine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
Table 54. North America Oxcarbazepine Sales by Country (2023-2028) & (M Unit)
Table 55. North America Oxcarbazepine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Oxcarbazepine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 58. Europe Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 59. Europe Oxcarbazepine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Oxcarbazepine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 62. Europe Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 63. Europe Oxcarbazepine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Oxcarbazepine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
Table 66. Europe Oxcarbazepine Sales by Country (2023-2028) & (M Unit)
Table 67. Europe Oxcarbazepine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Oxcarbazepine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 70. Asia Pacific Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 71. Asia Pacific Oxcarbazepine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Oxcarbazepine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 74. Asia Pacific Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 75. Asia Pacific Oxcarbazepine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Oxcarbazepine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Oxcarbazepine Sales by Region (2017-2022) & (M Unit)
Table 78. Asia Pacific Oxcarbazepine Sales by Region (2023-2028) & (M Unit)
Table 79. Asia Pacific Oxcarbazepine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Oxcarbazepine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 82. Latin America Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 83. Latin America Oxcarbazepine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Oxcarbazepine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 86. Latin America Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 87. Latin America Oxcarbazepine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Oxcarbazepine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
Table 90. Latin America Oxcarbazepine Sales by Country (2023-2028) & (M Unit)
Table 91. Latin America Oxcarbazepine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Oxcarbazepine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Oxcarbazepine Sales by Type (2017-2022) & (M Unit)
Table 94. Middle East and Africa Oxcarbazepine Sales by Type (2023-2028) & (M Unit)
Table 95. Middle East and Africa Oxcarbazepine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Oxcarbazepine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Oxcarbazepine Sales by Application (2017-2022) & (M Unit)
Table 98. Middle East and Africa Oxcarbazepine Sales by Application (2023-2028) & (M Unit)
Table 99. Middle East and Africa Oxcarbazepine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Oxcarbazepine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Oxcarbazepine Sales by Country (2017-2022) & (M Unit)
Table 102. Middle East and Africa Oxcarbazepine Sales by Country (2023-2028) & (M Unit)
Table 103. Middle East and Africa Oxcarbazepine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Oxcarbazepine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Novartis (Trileptal) Corporation Information
Table 106. Novartis (Trileptal) Description and Major Businesses
Table 107. Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Novartis (Trileptal) Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Novartis (Trileptal) Recent Developments
Table 110. Supernus Pharmaceuticals (Oxtellar XR) Corporation Information
Table 111. Supernus Pharmaceuticals (Oxtellar XR) Description and Major Businesses
Table 112. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Supernus Pharmaceuticals (Oxtellar XR) Recent Developments
Table 115. Sun Pharm Corporation Information
Table 116. Sun Pharm Description and Major Businesses
Table 117. Sun Pharm Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Sun Pharm Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sun Pharm Recent Developments
Table 120. Ranbaxy Pharmaceuticals Corporation Information
Table 121. Ranbaxy Pharmaceuticals Description and Major Businesses
Table 122. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Ranbaxy Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Ranbaxy Pharmaceuticals Recent Developments
Table 125. Jubilant Generics Corporation Information
Table 126. Jubilant Generics Description and Major Businesses
Table 127. Jubilant Generics Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Jubilant Generics Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Jubilant Generics Recent Developments
Table 130. Taro Pharmaceuticals Corporation Information
Table 131. Taro Pharmaceuticals Description and Major Businesses
Table 132. Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Taro Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Taro Pharmaceuticals Recent Developments
Table 135. Mylan Corporation Information
Table 136. Mylan Description and Major Businesses
Table 137. Mylan Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Mylan Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Mylan Recent Developments
Table 140. Stada Group Corporation Information
Table 141. Stada Group Description and Major Businesses
Table 142. Stada Group Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Stada Group Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Stada Group Recent Developments
Table 145. Glenmark Pharmaceuticals Corporation Information
Table 146. Glenmark Pharmaceuticals Description and Major Businesses
Table 147. Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Glenmark Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Glenmark Pharmaceuticals Recent Developments
Table 150. ANI Pharmaceuticals Corporation Information
Table 151. ANI Pharmaceuticals Description and Major Businesses
Table 152. ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. ANI Pharmaceuticals Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. ANI Pharmaceuticals Recent Developments
Table 155. Teva Pharmaceutical Corporation Information
Table 156. Teva Pharmaceutical Description and Major Businesses
Table 157. Teva Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Teva Pharmaceutical Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Teva Pharmaceutical Recent Developments
Table 160. Roxane Laboratories Corporation Information
Table 161. Roxane Laboratories Description and Major Businesses
Table 162. Roxane Laboratories Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 163. Roxane Laboratories Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Roxane Laboratories Recent Developments
Table 165. Nobelpharma Corporation Information
Table 166. Nobelpharma Description and Major Businesses
Table 167. Nobelpharma Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 168. Nobelpharma Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Nobelpharma Recent Developments
Table 170. Apotex Corporation Information
Table 171. Apotex Description and Major Businesses
Table 172. Apotex Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 173. Apotex Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Apotex Recent Developments
Table 175. Nexgen pharma Corporation Information
Table 176. Nexgen pharma Description and Major Businesses
Table 177. Nexgen pharma Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 178. Nexgen pharma Oxcarbazepine Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Nexgen pharma Recent Developments
Table 180. Amneal Pharmaceuticals Corporation Information
Table 181.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Divalproex Sodium Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81

Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......

Global Divalproex Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......

Global Quetiapine Fumarate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......

Global Clozapine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......

Global Trazodone Hydrochloride (API) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92

According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......

Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93

According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......

Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91

According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......

Global Risperidone Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......

Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028

Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101

Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs